Nashville General — Nashville, Tennessee

Nashville General is a clinical research site located in Nashville, Tennessee, United States 37208.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Nashville General has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, TNBC - Triple-Negative Breast Cancer, HR Positive/HER-2 Negative Breast Cancer.

Sponsors: Tempus AI.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nashville General?

Nashville General has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nashville General conducted?

Nashville General has 1 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, TNBC - Triple-Negative Breast Cancer, HR Positive/HER-2 Negative Breast Cancer.

Is Nashville General accredited by Crixeo Health?

Nashville General has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nashville General?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.